1. Home
  2. RDHL vs PRZO Comparison

RDHL vs PRZO Comparison

Compare RDHL & PRZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • PRZO
  • Stock Information
  • Founded
  • RDHL 2009
  • PRZO 2014
  • Country
  • RDHL Israel
  • PRZO Israel
  • Employees
  • RDHL N/A
  • PRZO N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • PRZO
  • Sector
  • RDHL Health Care
  • PRZO
  • Exchange
  • RDHL Nasdaq
  • PRZO Nasdaq
  • Market Cap
  • RDHL 8.2M
  • PRZO 7.8M
  • IPO Year
  • RDHL N/A
  • PRZO 2023
  • Fundamental
  • Price
  • RDHL $5.63
  • PRZO $1.64
  • Analyst Decision
  • RDHL
  • PRZO
  • Analyst Count
  • RDHL 0
  • PRZO 0
  • Target Price
  • RDHL N/A
  • PRZO N/A
  • AVG Volume (30 Days)
  • RDHL 10.8K
  • PRZO 4.3M
  • Earning Date
  • RDHL 08-29-2024
  • PRZO 03-26-2025
  • Dividend Yield
  • RDHL N/A
  • PRZO N/A
  • EPS Growth
  • RDHL N/A
  • PRZO N/A
  • EPS
  • RDHL N/A
  • PRZO N/A
  • Revenue
  • RDHL $3,707,000.00
  • PRZO $558,382.00
  • Revenue This Year
  • RDHL $224.90
  • PRZO N/A
  • Revenue Next Year
  • RDHL $82.69
  • PRZO N/A
  • P/E Ratio
  • RDHL N/A
  • PRZO N/A
  • Revenue Growth
  • RDHL N/A
  • PRZO N/A
  • 52 Week Low
  • RDHL $5.41
  • PRZO $0.49
  • 52 Week High
  • RDHL $20.28
  • PRZO $3.16
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 40.41
  • PRZO 47.25
  • Support Level
  • RDHL $5.80
  • PRZO $1.71
  • Resistance Level
  • RDHL $6.26
  • PRZO $1.77
  • Average True Range (ATR)
  • RDHL 0.31
  • PRZO 0.12
  • MACD
  • RDHL 0.01
  • PRZO -0.03
  • Stochastic Oscillator
  • RDHL 19.33
  • PRZO 34.67

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About PRZO ParaZero Technologies Ltd.

ParaZero Technologies Ltd is an aerospace company that is focused on drone safety systems and engaged in the business of designing, developing, and providing autonomous parachute safety systems for commercial drones, also known as unmanned aerial systems. The ParaZero SafeAir system of the comapany applies real-time data analytics to identify and mitigate flight risks autonomously and increase safety for bystanders while protecting the loss of expensive drones, equipment, and payloads.

Share on Social Networks: